Entheon BiomedicalENTBF Market Cap is $0.49 Mil as of Jun. 28, 2026. The stock has 2 warning signs investors should review. Among 1,429 Biotechnology companies, Entheon Biomedical ranks worse than 98.81% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Entheon Biomedical's share price for the quarter that ended in Feb. 2026 was $0.07944. Entheon Biomedical's Shares Outstanding (EOP) for the quarter that ended in Feb. 2026 was 13.86 Mil. Therefore, Entheon Biomedical's market cap for the quarter that ended in Feb. 2026 was $1.10 Mil.
Entheon Biomedical's quarterly market cap
declined
from Aug. 2025 ($0.96 Mil) to Nov. 2025 ($0.82 Mil) but then
increased
from Nov. 2025 ($0.82 Mil) to Feb. 2026 ($1.10 Mil).
Entheon Biomedical's annual market cap
increased
from Nov. 2023 ($0.46 Mil) to Nov. 2024 ($0.89 Mil) but then
declined
from Nov. 2024 ($0.89 Mil) to Nov. 2025 ($0.82 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Entheon Biomedical's Enterprise Value for Today is $0.30 Mil.
Entheon Biomedical (OTCPK:ENTBF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Entheon Biomedical Market Cap Related Terms
Entheon Biomedical Market Cap Historical Data
* Premium members only.
The historical data trend for Entheon Biomedical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Entheon Biomedical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Entheon Biomedical Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Entheon Biomedical's Market Cap distribution charts can be found below:
* The bar in red indicates where Entheon Biomedical's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Entheon Biomedical's Market Cap for the fiscal year that ended in Nov. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Entheon Biomedical (ENTBF) has a Market Cap of $0.49 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Entheon Biomedical and its competitors. According to the industry distribution chart, Entheon Biomedical ranks #1412 out of 1429 companies in the Biotechnology industry, placing it in the top 98.8%.
Is Entheon Biomedical's Market Cap too high?
Entheon Biomedical's current Market Cap is $0.49 Mil. The Biotechnology industry median Market Cap is 112.70. Entheon Biomedical's value of $0.49 Mil is 99.6% below this industry median. Based on the distribution chart, Entheon Biomedical ranks #1412 out of 1429 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Entheon Biomedical's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Entheon Biomedical ranks #1412 out of 1429 companies for Market Cap. This places Entheon Biomedical in the lower half of its industry. The industry median Market Cap is 112.70. Entheon Biomedical's value of $0.49 Mil is 99.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 112.70, based on 1,429 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Entheon Biomedical's current Market Cap of $0.49 Mil is 99.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Entheon Biomedical and its competitors. For the Biotechnology industry, the median Market Cap is 112.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Entheon Biomedical's current Market Cap is $0.49 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entheon Biomedical stock overvalued right now?
Entheon Biomedical (ENTBF) has a current Market Cap of $0.49 Mil. The current Market Cap is $0.49 Mil and 99.6% below the Biotechnology industry median of 112.70. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Entheon Biomedical (ENTBF), the current Market Cap is $0.49 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ENTBF has been successfully added to your 